Françoise Ballereau

594 total citations
17 papers, 444 citations indexed

About

Françoise Ballereau is a scholar working on Geriatrics and Gerontology, Toxicology and Applied Microbiology and Biotechnology. According to data from OpenAlex, Françoise Ballereau has authored 17 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Geriatrics and Gerontology, 5 papers in Toxicology and 5 papers in Applied Microbiology and Biotechnology. Recurrent topics in Françoise Ballereau's work include Pharmaceutical Practices and Patient Outcomes (9 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers) and Antibiotic Use and Resistance (5 papers). Françoise Ballereau is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (9 papers), Pharmacovigilance and Adverse Drug Reactions (5 papers) and Antibiotic Use and Resistance (5 papers). Françoise Ballereau collaborates with scholars based in France, Switzerland and Canada. Françoise Ballereau's co-authors include M Speich, Alain Pineau, Michel Bourin, Pascale Jolliet, Nathalie Asseray, G. Potel, Anne Chiffoleau, Jean-Benoît Hardouin, Patrice Queneau and J. Bouget and has published in prestigious journals such as Clinica Chimica Acta, Clinical Pharmacokinetics and European Journal of Epidemiology.

In The Last Decade

Françoise Ballereau

17 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Françoise Ballereau France 9 113 77 58 57 51 17 444
Chandra Bhushan Tripathi India 15 39 0.3× 42 0.5× 36 0.6× 37 0.6× 26 0.5× 50 646
Shadi Farsaei Iran 15 187 1.7× 32 0.4× 66 1.1× 33 0.6× 22 0.4× 42 750
Nattawut Leelakanok Thailand 13 242 2.1× 17 0.2× 88 1.5× 30 0.5× 21 0.4× 60 746
Gerald K. McEvoy United States 5 82 0.7× 29 0.4× 142 2.4× 16 0.3× 10 0.2× 8 912
Manish Barvaliya India 13 72 0.6× 70 0.9× 59 1.0× 8 0.1× 47 0.9× 48 588
Fikret Vehbi İzzettin Türkiye 15 233 2.1× 29 0.4× 107 1.8× 20 0.4× 53 1.0× 52 723
Catherine A. Hammett‐Stabler United States 18 26 0.2× 125 1.6× 169 2.9× 21 0.4× 8 0.2× 45 1.3k
Yahaya Hassan Malaysia 13 201 1.8× 17 0.2× 79 1.4× 27 0.5× 24 0.5× 50 630
Yet Hoi Hong Malaysia 13 91 0.8× 19 0.2× 65 1.1× 13 0.2× 38 0.7× 22 477
Doris Rušić Croatia 14 59 0.5× 20 0.3× 19 0.3× 22 0.4× 105 2.1× 58 596

Countries citing papers authored by Françoise Ballereau

Since Specialization
Citations

This map shows the geographic impact of Françoise Ballereau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Françoise Ballereau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Françoise Ballereau more than expected).

Fields of papers citing papers by Françoise Ballereau

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Françoise Ballereau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Françoise Ballereau. The network helps show where Françoise Ballereau may publish in the future.

Co-authorship network of co-authors of Françoise Ballereau

This figure shows the co-authorship network connecting the top 25 collaborators of Françoise Ballereau. A scholar is included among the top collaborators of Françoise Ballereau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Françoise Ballereau. Françoise Ballereau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Asseray, Nathalie, et al.. (2014). Establishing a pharmacy presence in the emergency department: opportunities and challenges in the French setting. International Journal of Clinical Pharmacy. 36(3). 471–475. 9 indexed citations
3.
Ballereau, Françoise, et al.. (2014). Adverse Drug Event Nonrecognition in Emergency Departments: An Exploratory Study on Factors Related to Patients and Drugs. Journal of Emergency Medicine. 46(6). 857–864. 20 indexed citations
4.
Asseray, Nathalie, Françoise Ballereau, Béatrice Trombert‐Paviot, et al.. (2013). Frequency and Severity of Adverse Drug Reactions Due to Self-Medication: A Cross-Sectional Multicentre Survey in Emergency Departments. Drug Safety. 36(12). 1159–1168. 60 indexed citations
5.
Batard, Éric, Emmanuel Montassier, Françoise Ballereau, & G. Potel. (2012). De la consommation d’antibiotiques aux résistances bactériennes : l’exemple de la résistance d’ Escherichia coli aux quinolones. 17(4). 294–301. 1 indexed citations
6.
Batard, Éric, David Boutoille, Jean-Benoît Hardouin, et al.. (2012). Relationship between hospital antibiotic use and quinolone resistance in Escherichia coli. International Journal of Infectious Diseases. 17(4). e254–e258. 15 indexed citations
7.
Asseray, Nathalie, et al.. (2012). Étude des comportements d’automédication chez les patients admis dans un service d’urgences médicales. Therapies. 67(5). 447–455. 5 indexed citations
8.
Asseray, Nathalie, et al.. (2012). Implementing a clinical pharmacy survey of adverse drug events in a French emergency department. International Journal of Clinical Pharmacy. 34(6). 902–910. 13 indexed citations
9.
Asseray, Nathalie, et al.. (2012). A questionnaire to document self‐medication history in adult patients visiting emergency departments. Pharmacoepidemiology and Drug Safety. 22(2). 151–159. 8 indexed citations
10.
Ballereau, Françoise, Jean-Benoît Hardouin, Anne Chiffoleau, et al.. (2012). Assessment of adverse drug event recognition by emergency physicians in a French teaching hospital. Emergency Medicine Journal. 30(1). 63–67. 29 indexed citations
12.
Asseray, Nathalie, Christophe Leux, François Garnier, et al.. (2009). Utilisation des tests de diagnostic rapide de l’angine en médecine générale. Enquête réalisée de novembre 2006 à janvier 2007 dans les Pays de la Loire. La Presse Médicale. 39(4). e77–e85. 7 indexed citations
13.
Moret, L., et al.. (2004). L’information du patient à l’hôpital, un partage implicite des rôles entre professionnels ?. La Presse Médicale. 33(20). 1431–1436. 1 indexed citations
14.
Prazuck, Thiérry, et al.. (2002). Quality Control of Antibiotics Before the Implementation of an STD Program in Northern Myanmar. Sexually Transmitted Diseases. 29(11). 624–627. 21 indexed citations
15.
Speich, M, Alain Pineau, & Françoise Ballereau. (2001). Minerals, trace elements and related biological variables in athletes and during physical activity. Clinica Chimica Acta. 312(1-2). 1–11. 144 indexed citations
16.
Ballereau, Françoise, M Speich, & Véronique Apaire-Marchais. (1999). Natural Haemophilus influenzae type b capsular polysaccharide antibodies in 412 infants and children from West Africa (Burkina-Faso) and France: A cross-sectional serosurvey. European Journal of Epidemiology. 15(6). 577–582. 5 indexed citations
17.
Bourin, Michel, Pascale Jolliet, & Françoise Ballereau. (1997). An Overview of the Clinical Pharmacokinetics of X-Ray Contrast Media. Clinical Pharmacokinetics. 32(3). 180–193. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026